Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up
Michael Lake,
Christine S. Shusted,
Hee-Soon Juon,
Russell K. McIntire,
Charnita Zeigler-Johnson,
Nathaniel R. Evans,
Gregory C. Kane,
Julie A. Barta
Affiliations
Michael Lake
The Jane and Leonard Korman Respiratory Institute, Division of Pulmonary and Critical Care Medicine
Christine S. Shusted
The Jane and Leonard Korman Respiratory Institute, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University
Hee-Soon Juon
Department of Medical Oncology, Division of Population Science, Thomas Jefferson University
Russell K. McIntire
Jefferson College of Population Health, Thomas Jefferson University
Charnita Zeigler-Johnson
Department of Medical Oncology, Division of Population Science, Thomas Jefferson University
Nathaniel R. Evans
The Jane and Leonard Korman Respiratory Institute, Department of Surgery, Division of Thoracic Surgery
Gregory C. Kane
The Jane and Leonard Korman Respiratory Institute, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University
Julie A. Barta
The Jane and Leonard Korman Respiratory Institute, Division of Pulmonary and Critical Care Medicine
Abstract Background Racial disparities are well-documented in preventive cancer care, but they have not been fully explored in the context of lung cancer screening. We sought to explore racial differences in lung cancer screening outcomes within a lung cancer screening program (LCSP) at our urban academic medical center including differences in baseline low-dose computed tomography (LDCT) results, time to follow-up, adherence, as well as return to annual screening after additional imaging, loss to follow-up, and cancer diagnoses in patients with positive baseline scans. Methods A historical cohort study of patients referred to our LCSP was conducted to extract demographic and clinical characteristics, smoking history, and lung cancer screening outcomes. Results After referral to the LCSP, blacks had significantly lower odds of receiving LDCT compared to whites, even while controlling for individual lung cancer risk factors and neighborhood-level factors. Blacks also demonstrated a trend toward delayed follow-up, decreased adherence, and loss to follow-up across all Lung-RADS categories. Conclusions Overall, lung cancer screening annual adherence rates were low, regardless of race, highlighting the need for increased patient education and outreach. Furthermore, the disparities in race we identified encourage further research with the purpose of creating culturally competent and inclusive LCSPs.